Where an early-stage number actually comes from, why pre- and post-money is not a detail, and the terms that cost more than the price.
7 min readEarly-stage valuation is not a calculation. There are no cash flows to discount and no comparables that mean much, so the number is set by what the round needs to be, how much dilution is normal at the stage, and how much competition there is for the deal. Working backwards from those three gets you closer than any model.
A round is usually 10-25% of the company. So a ₹8 crore raise at a standard 20% dilution implies a ₹40 crore post-money valuation, and the negotiation is about moving that percentage. This is why round size and valuation are not independent decisions: change one and the other moves with it.
At pre-seed, price is often deferred with a convertible note or a SAFE-style instrument, converting at the next priced round with a discount and usually a cap. The cap is the real valuation negotiation — it sets the worst price the investor will pay. In India, note that a SAFE is not a native instrument under the Companies Act; the common domestic equivalent is a CCPS or a convertible note issued under the relevant RBI and Companies Act provisions, and the structure is worth a lawyer's hour before you sign, not after.
This page is general information, not legal, tax or financial advice. Term sheets are binding in ways that are not obvious from reading them; get an experienced startup lawyer before you sign one.
General information for founders, not legal, tax or financial advice. Fundraising documents are binding in ways that are not obvious from reading them — take professional advice on anything you are about to sign.